Discover
ARCT
Arcturus Therapeutics Holdings Inc.
7.45
1 x 7.44
2 x 7.45
bid
ask
+
0.40
5.66%
01:32 PM
timesize
| Ytd | 21.52% | |
| 1y | -34.60% |
7.07
day range
7.66
5.50
52 week range
24.17
| Open | 7.07 | Prev Close | 7.05 | Low | 7.07 | High | 7.66 | Mkt Cap | 212.04M |
| Vol | 624.71K | Avg Vol | 489.63K | EPS | -2.81 | P/E | -2.65 | Forward P/E | -7.41 |
| Beta | 2.39 | Short Ratio | 9.41 | Inst. Own | 90.16% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 6.78 | 200-d Avg | 7.44 | 1yr Est | 79.47 |
| Income Statement | |||
| Total Revenue | 2.96M | ||
| Revenues (USD) | 2.96M | ||
| Gross Profit | 2.96M | ||
| Operating Expenses | 28.56M | ||
| Research and Development Expense | 17.52M | ||
| Selling, General and Administrative Expense | 10.99M | ||
| Operating Income | -25.60M | ||
| Net Income | -23.78M | ||
| Net Income Common Stock | -23.78M | ||
| Net Income Common Stock (USD) | -23.78M | ||
| Consolidated Income | -23.78M | ||
| Earnings per Basic Share | -0.84 | ||
| Earnings per Basic Share (USD) | -0.84 | ||
| Earnings per Diluted Share | -0.84 | ||
| Earning Before Interest & Taxes (EBIT) | -23.78M | ||
| Earning Before Interest & Taxes (USD) | -23.78M | ||
| Weighted Average Shares | 28.42M | ||
| Weighted Average Shares Diluted | 28.42M | ||
| Balance Sheet | |||
| Cash and Equivalents | 191.48M | ||
| Cash and Equivalents (USD) | 191.48M | ||
| Investments | 2.03M | ||
| Investments Non-Current | 2.03M | ||
| Trade and Non-Trade Receivables | 1.81M | ||
| Current Assets | 197.16M | ||
| Property, Plant & Equipment Net | 25.12M | ||
| Total Assets | 224.31M | ||
| Total Debt | 18.97M | ||
| Current Liabilities | 33.54M | ||
| Debt Non-Current | 18.97M | ||
| Total Liabilities | 52.50M | ||
| Accumulated Retained Earnings (Deficit) | -565.34M | ||
| Shareholders Equity | 171.81M | ||
| Shareholders Equity (USD) | 171.81M | ||
| Assets Non-Current | 27.15M | ||
| Total Debt (USD) | 18.97M | ||
| Deferred Revenue | 6.28M | ||
| Liabilities Non-Current | 18.97M | ||
| Trade and Non-Trade Payables | 4.41M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 643.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -19.89M | ||
| Capital Expenditure | 18.00K | ||
| Net Cash Flow from Investing | 18.00K | ||
| Net Cash Flow from Operations | -19.91M | ||
| Share Based Compensation | 4.23M | ||